|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||1.66|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 7, 2018 - Nov 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Stereotaxis, Inc. (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will present at the OTCQX Virtual Investor Conference for Domestic Companies. Management will provide an overview of the Company's technology and business during the presentation on Thursday, October 4, 2018 at 9:30 a.m. ET. OTC Markets has sponsored several OTCQX Virtual Conferences with previous conferences reaching over 1,000 investors.
Progress on strategic internal innovation and external collaborations Continued growth in recurring revenue Positive cash flow from operations Reaffirming 2018 expectations Conference call today at 10:00 ...
LOUIS, July 31, 2018-- Stereotaxis, Inc., the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 ...
NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Stereotaxis, Inc. (NASDAQ: STXS ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 10:00 AM Eastern Time. To ...
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Stereotaxis Inc. ( OTCQX: STXS ) and OurPet's Co. ( OTCQX: OPCO ), ...